John Oyler

Co-founder, Chairman and CEO, BeOne Medicines

Basel, Switzerland

About

John Oyler is a co-founder of BeOne Medicines, the oncology company formerly known as BeiGene, and serves as its Chairman and Chief Executive Officer. He has been on the board since October 2010. BeOne develops treatments for cancer, and its latest quarterly report lists Basel, Switzerland as its headquarters. Before BeOne he founded Telephia and worked in management consulting at McKinsey & Company.

Oyler earned a B.S. from the Massachusetts Institute of Technology in June 1990 and an M.B.A. from Stanford University in January 1996. His earlier roles include Co-CEO of Genta, Founder and President of Telephia, CEO of Galenea Corp., and President and CEO of BioDuro. Other biotech and pharmaceutical chief executives with pages on Whoo include Samarth Kulkarni of CRISPR Therapeutics and Stephane Bancel of Moderna.

Whoo compiled this page from public sources: BeOne 2026 proxy statement (SEC), BeOne Form 10-Q, September 2026 (SEC), Wikipedia: John V. Oyler. It is not affiliated with or endorsed by John Oyler. Are you John Oyler? Claim this page, or write to [email protected] to correct or remove it. Last updated: 2026-11-18.

Want a page like this? Create yours from your résumé.

Experience

Co-founder, Chairman and Chief Executive Officer — BeOne Medicines


2010 – Present

  • Board member since October 2010

President and CEO — BioDuro, LLC

Chief Executive Officer — Galenea Corp.

Founder and President — Telephia, Inc.

Co-CEO — Genta, Inc.

Management Consultant — McKinsey & Company

Education

MBA — Stanford University


1996

BS — Massachusetts Institute of Technology


1990

Projects